PharmaNewsIntelligence ranked 45th on FeedSpot's list of top 60 pharma news websites! Check out the entire list here: https://lnkd.in/gVNiTcyK.
PharmaNewsIntelligence
Online Audio and Video Media
Danvers, Massachusetts 411 followers
Leveraging Drug Innovations to Deliver Better Care
About us
The editors at PharmaNewsIntelligence share insights with providers and payers interested in the impact of pharmaceuticals on healthcare spending, quality of care, and breakthrough therapies.
- Website
-
https://pharmanewsintel.com/
External link for PharmaNewsIntelligence
- Industry
- Online Audio and Video Media
- Company size
- 11-50 employees
- Headquarters
- Danvers, Massachusetts
Updates
-
Teva launches authorized generic of Victoza (liraglutide) in the United States, potentially reducing costs, improving access, and enhancing diabetes care outcomes. Written by Alivia Kaylor, MSc #glp1 #genericdrugs #diabetes https://lnkd.in/eQZJMJzz
Teva launches authorized generic of Victoza in the US
pharmanewsintel.com
-
The endocannabinoid system, a complex cell-signaling network, is vital in maintaining physiological balance by regulating key processes such as mood, pain, and immune response. Written by Alivia Kaylor, MSc #cannabis #cns #ecs https://lnkd.in/eDHByv_Q
Understanding the endocannabinoid system’s role in maintaining physiological balance
pharmanewsintel.com
-
A report from the Congressional Budget Office estimates that doubling hepatitis C treatment among Medicaid enrollees could save $7 billion. Written by Veronica Salib #budget #hepatitis #medicaid https://lnkd.in/e_BW9wxb
Expanding access to hepatitis C treatment would reduce healthcare cost
pharmanewsintel.com
-
The new vaccine is thought to protect against approximately 85% of invasive pneumococcal disease in adults 65 years of age and older. Written by Veronica Salib #pcv #infectiousdisease #vaccines https://lnkd.in/eeySGH3Y
FDA approves Merck’s newest pneumococcal vaccine
pharmanewsintel.com
-
The tool is marketed as a suite of central laboratory solutions for investigator sites, which should accelerate the speed of trials. Written by Veronica Salib #clinicaltrials #diversity #research https://lnkd.in/ecVaBCHV
Labcorp Global Trial Connect offers tools for clinical trials
pharmanewsintel.com
-
The USP's 2023 report highlights economic factors driving drug shortages, emphasizing the need for policy reforms, pricing adjustments, and supply chain diversification. Written by Alivia Kaylor, MSc #drugshortages #policy #supplychain https://lnkd.in/e4j8fwbi
2023 USP Report highlights economic factors driving drug shortages
pharmanewsintel.com
-
Although up to 82% of plans cover GLP-1 medications for diabetes, 1% or less cover GLP-1 drugs for obesity, such as Saxenda, Wegovy, and Zepbound. Written by Veronica Salib #glp1 #obesity #diabetes https://lnkd.in/ec7Jhbnr
Only 1% of ACA Marketplace plans cover GLP-1 drugs for obesity
pharmanewsintel.com
-
The United States FDA and the Department of Justice will collaborate to fight against the unlawful distribution and sale of e-cigarettes. Written by Veronica Salib #fda #doj #regulation https://lnkd.in/ecJaGySi
Multi-agency task force collaborates to address illegal e-cigarettes
pharmanewsintel.com
-
On June 10, a panel of FDA advisors unanimously voted in favor of approving Eli Lilly’s new Alzheimer’s disease drug, donanemab. Written by Veronica Salib #dementia #FDA #neurodegenerative https://lnkd.in/eMhsaPd3
FDA advisory panel votes in favor of Lilly’s Alzheimer’s drug
pharmanewsintel.com